Min Zhao

Title: Min Zhao - Innovator in Respiratory Syncytial Virus Research

Introduction

Min Zhao is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of medical research, particularly in the development of solutions for respiratory syncytial virus (RSV) infections. His innovative work has led to the creation of a patent that addresses critical health challenges associated with RSV.

Latest Patents

Min Zhao holds a patent for an epitope of the RSV fusion protein and an antibody recognizing the same. The invention relates to an epitope peptide, which can be utilized in the prevention of RSV infection. It includes a recombinant protein comprising the epitope peptide and a carrier protein, along with various applications of the epitope peptide and the recombinant protein. Additionally, the patent covers an antibody against the epitope peptide, a cell line for generating the antibody, and its uses. Furthermore, the invention also pertains to a vaccine or pharmaceutical composition that includes the recombinant protein or the antibody, aimed at preventing symptoms associated with RSV infection. Min Zhao has 1 patent to his name.

Career Highlights

Throughout his career, Min Zhao has worked with esteemed institutions such as Xiamen University and Xiamen Innovax Biotech Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Min Zhao has collaborated with notable colleagues, including Zizheng Zheng and Jason Scott McLellan. These partnerships have enhanced his research efforts and fostered innovation in the field of virology.

Conclusion

Min Zhao's contributions to the understanding and prevention of respiratory syncytial virus infections highlight his role as an influential inventor in the medical research field. His innovative patent and collaborations reflect his commitment to advancing healthcare solutions.